{"id":348,"date":"2017-01-13T09:53:00","date_gmt":"2017-01-13T09:53:00","guid":{"rendered":"https:\/\/sites.thesrgroup.com\/taylorroot\/?p=348"},"modified":"2022-04-13T09:59:40","modified_gmt":"2022-04-13T09:59:40","slug":"market-update-pharmaceutical-sector","status":"publish","type":"post","link":"https:\/\/srgroup.highrise.digital\/nl\/market-insight\/market-update-pharmaceutical-sector\/","title":{"rendered":"Market Update &#8211; Pharmaceutical Sector"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Market Outlook<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Recruitment activity in the pharmaceutical, medical devices and biotechnology remained fairly active in 2016, despite a slowdown in the Asia Pacific region.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Besides replacement positions, recruitment activity was driven also by newly created positions at the junior to mid\u2010levels. In particular, these requirements were driven by business growth in the south east Asian region. Singapore\u2010admitted lawyers with relevant and region industry are often preferred. Besides recruitment from established and mature pharmaceutical players, we have also seen US, UK or Europe headquartered multinationals recruit for their first APAC counsel.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Another notable trend we\u2019ve seen is a preference for candidates with strong Mandarin capabilities. China is becoming an increasingly important market for a number of the pharmaceutical and medical technology multinationals. There is a strong preference for the candidate to be based in Singapore however, so they are able to support the south-east Asia region in addition to the mainland China business.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><th>PQE<\/th><th>Base Salary Range<\/th><th>Bonus Range<\/th><\/tr><tr><td>1 \u2010 3<\/td><td>60,000 SGD \u2013 90,000 SGD<\/td><td>10 \u2010 15%<\/td><\/tr><tr><td>3 \u2010 5<\/td><td>80,000 SGD \u2013 140,000 SGD<\/td><td>10 \u2010 15%<\/td><\/tr><tr><td>5 \u2010 7<\/td><td>100,000 SGD \u2013 160,000 SGD<\/td><td>10 \u2010 20%<\/td><\/tr><tr><td>7 \u2010 9<\/td><td>150,000 SGD \u2013 220,000 SGD<\/td><td>15 \u2010 20%<\/td><\/tr><tr><td>9 \u2010 11<\/td><td>180,000 SGD \u2013 250,000 SGD<\/td><td>15 \u2010 25%<\/td><\/tr><tr><td>SEA Head of Legal<\/td><td>200,000 SGD \u2013 280,000 SGD<\/td><td>25 \u2010 40%<\/td><\/tr><tr><td>APAC Head of Legal<\/td><td>250,000 SGD \u2013 500,000 SGD<\/td><td>30 \u2010 50%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Candidate profiles:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Candidate 957911<\/em><br>\u2022 5 years\u2019 PQE<br>\u2022 Legal Counsel with a European pharmaceutical multinational<br>\u2022 Strong ASEAN experience, provides legal support to Singapore, Malaysia, Indonesia, Thailand and Vietnam<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Candidate 623181<\/em><br>\u2022 20+ years\u2019 PQE<br>\u2022 Close to twenty years\u2019 in\u2010house experience in the life sciences and medical technology industries<br>\u2022 Strong APAC legal and regulatory experience<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Candidate 1117841<\/em><br>\u2022 20+ years\u2019 PQE<br>\u2022 5\u20106 years\u2019 experience with a global medical technology multinational<br>\u2022 Provides legal, commercial and transactional support for businesses<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For more information, please contact us today.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Market Outlook Recruitment activity in the pharmaceutical, medical devices and biotechnology remained fairly active in 2016, despite a slowdown in the Asia Pacific region. Besides replacement positions, recruitment activity was driven also by newly created positions at the junior to mid\u2010levels. In particular, these requirements were driven by business growth in the south east Asian [&hellip;]<\/p>\n","protected":false},"author":266,"featured_media":349,"comment_status":"open","ping_status":"open","sticky":false,"template":"templates\/post-original.php","format":"standard","meta":{"_acf_changed":false,"_cn_metabox_post_checkbox_dont_send_once":false,"_cn_metabox_post_checkbox_dont_send_ever":false,"footnotes":""},"categories":[40,41],"tags":[],"hd_author":[],"class_list":["post-348","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-insight","category-market-update"],"acf":[],"_links":{"self":[{"href":"https:\/\/srgroup.highrise.digital\/nl\/wp-json\/wp\/v2\/posts\/348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/srgroup.highrise.digital\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/srgroup.highrise.digital\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/srgroup.highrise.digital\/nl\/wp-json\/wp\/v2\/users\/266"}],"replies":[{"embeddable":true,"href":"https:\/\/srgroup.highrise.digital\/nl\/wp-json\/wp\/v2\/comments?post=348"}],"version-history":[{"count":0,"href":"https:\/\/srgroup.highrise.digital\/nl\/wp-json\/wp\/v2\/posts\/348\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/srgroup.highrise.digital\/nl\/wp-json\/wp\/v2\/media\/349"}],"wp:attachment":[{"href":"https:\/\/srgroup.highrise.digital\/nl\/wp-json\/wp\/v2\/media?parent=348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/srgroup.highrise.digital\/nl\/wp-json\/wp\/v2\/categories?post=348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/srgroup.highrise.digital\/nl\/wp-json\/wp\/v2\/tags?post=348"},{"taxonomy":"hd_author","embeddable":true,"href":"https:\/\/srgroup.highrise.digital\/nl\/wp-json\/wp\/v2\/hd_author?post=348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}